Forgot password

Not a Member?

Federal Funding of HIV Programs


The American Academy of HIV Medicine (AAHIVM) and its members support the adequate funding of federal programs for HIV/AIDS, care and treatment as the foremost funding priority.


Federal and state programs for HIV/AIDS have been chronically underfunded. This underfunding has real repercussions for the medical health and well-being of people infected with a potentially fatal disease.

Most HIV providers report that the Medicare, Medicaid, and Ryan White programs do not currently reimburse medical care at actual cost.

The Centers for Disease Control and Prevention estimate that there are 56,000 new HIV infections per year in the United States. Need for care, treatment, and services for people living with HIV grows annually, but federal funding of HIV programs historically grows at a much slower rate.

One example of this is the AIDS Drug Assistance Programs (ADAPs). AIDS Drug Assistance Programs are critical in providing medications to people living with HIV/AIDS who have no other access. Unfortunately, many state ADAPs have been forced to cut services by reducing eligibility criteria, changing formularies, and closing enrollment. In 2010, many states have put individuals on waiting lists to receive their life-saving and life-sustaining medications through this program.

Success at fighting HIV requires financial investment to help sustain a long-term effort against the disease. The federal government must ensure that people living with the disease have adequate access to care and treatment.

To see examples of our policy work in this area, visit our
National Issues page.